MNOV
$2.49
Medicinova
$.05
2.05%
Earnings Details
1st Quarter March 2022
Tweet Share Watch
Summary

Medicinova (MNOV) Recent Earnings

Medicinova (MNOV) reported a 1st Quarter March 2022 loss of $0.07 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.09 per share. Revenue fell 100.0% compared to the same quarter a year ago.

MediciNova Inc is a development stage biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.

Results
Reported Earnings
($0.07)
Earnings Whisper
-
Consensus Estimate
($0.09)
Reported Revenue
Revenue Estimate
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release